CN
c1banner.jpg c1bannerph.jpg

CRDMO

Service Introduction

Sinopep's elite CMC team offers end-to-end support, steering projects from conception to market launch seamlessly.  With tailored solutions, industry-leading expertise, and a commitment to excellence, we ensure meticulous guidance and regulatory compliance, accelerating your product's journey to success.

Frame 1321320116.svg

Oligonucleotide NCEs

c1_img_07.jpg
Contact Us

Our oligonucleotide CRDMO platform located in “China Biopharma Town” in Hangzhou city.  This R&D center and fully GMP compliance pilot plant facility is equipped with top-of-the-line oligo synthesis and purification equipment from Cytiva.  Meanwhile, our corresponding analytical service platform is equipped with the cutting-edge analytical instruments such as QE Plus Orbitrap, XEVO G3 QTof, Maldi-Tof, Circular Dichroism, and ICP-MS etc. to perform structure elucidation of highly complexed oligonucleotide structures and carry out extremely challenging studies about impurities associated with these type of drug candidates.  There are more than 60 scientists in this organization and over 50% of the team members has advanced graduate degrees and with relevant industrial experience in this field.  We have collaborated on with multiple domestic and international partners on ASO (antisense oligonucleotides), SiRNA, PMO, as well as various types drug conjugates.

Synthetic Small Molecules

Technology Platform
  • Project Code
  • Project Type
  • Classification
  • Status
  • AT008
    CDMO (ANDA)
    SiRNA
    Process development and optimization
  • AT017
    CDMO (ANDA)
    SiRNA
    Process development (Lab scale)
  • AT018
    CDMO (ANDA)
    SiRNA
    Process development (Lab scale)
  • AT019
    CDMO (ANDA)
    SiRNA
    Process development (Lab scale)
  • AT030
    CDMO (NDA)
    SiRNA
    Toxicology batch
  • AT041
    CDMO (NDA)
    SiRNA
    Process development (Lab scale)
  • AT005
    CDMO (ANDA)
    ASO
    Engineering batch
  • AT003
    CRO
    ASO,vaccine adjuvant
    Process development (Lab scale)
  • AT035
    CRO
    ASO,vaccine adjuvant
    Process development (Lab scale)
  • AT037
    CRO
    ASO,vaccine adjuvant
    Process development (Lab scale)

Production Equipment

  • Synthesis

    • OligoSynt*3

    • Unique AutoOligo100*2

    • OligoPilot

  • Purification

    • ÄKTA Avant25*1

    • ÄKTA Avant150*1

    • ÄKTA Pilot600*1

    • ÄKTA Process*1

  • UF / DF / TFE

    • ÄKTA Flux6*1

    • Uniflux 10*1

    • Uniflux 30*1

    • Thin Film Evaporator (CEP-Lab, CEP-1S)

  • Lyophilization

    • Scientz Lyophilization (0.5㎡)

    • Truking Lyophilization (5㎡)